Cabaletta Bio, Inc.

NasdaqGS:CABA 株式レポート

時価総額:US$196.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Cabaletta Bio マネジメント

マネジメント 基準チェック /24

Cabaletta Bio'sの CEO はSteven Nichtbergerで、 Jan2017年に任命され、 の在任期間は 7.42年です。 の年間総報酬は$ 4.81Mで、 12.4%給与と87.6%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の2.8%を直接所有しており、その価値は$ 12.63M 。経営陣と取締役会の平均在任期間はそれぞれ5年と4.4年です。

主要情報

Steven Nichtberger

最高経営責任者

US$4.8m

報酬総額

CEO給与比率12.4%
CEO在任期間7.7yrs
CEOの所有権2.8%
経営陣の平均在職期間3yrs
取締役会の平均在任期間4.7yrs

経営陣の近況

Recent updates

We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Sep 04
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Cabaletta Bio: Next Data Readout Needs To Be Mic Drop Moment

Jun 28

Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

May 22
Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Cabaletta Bio: Two Differentiated CAR-T Platforms To Carry It Forward

Jan 31

Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Dec 28
Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Situation

Sep 12
Here's Why We're Not Too Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Situation

Here's Why We're Not Too Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Situation

Jun 04
Here's Why We're Not Too Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Situation

Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Feb 11
Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

We Think Cabaletta Bio (NASDAQ:CABA) Needs To Drive Business Growth Carefully

Oct 20
We Think Cabaletta Bio (NASDAQ:CABA) Needs To Drive Business Growth Carefully

We Think Cabaletta Bio (NASDAQ:CABA) Needs To Drive Business Growth Carefully

Jul 07
We Think Cabaletta Bio (NASDAQ:CABA) Needs To Drive Business Growth Carefully

Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Mar 24
Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Dec 09
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate

Aug 05
We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate

Cabaletta Bio EPS beats by $0.08

May 03

Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

Apr 12
Cabaletta Bio (NASDAQ:CABA) Is In A Good Position To Deliver On Growth Plans

What Percentage Of Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Do Insiders Own?

Feb 19
What Percentage Of Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Do Insiders Own?

Chardan Capital initiates Cabaletta Bio with Buy rating

Jan 08

We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Dec 28
We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely

Dosing underway in Cabaletta Bio's DSG3-CAART study in a rare skin blistering disorder

Dec 09

Cabaletta Bio +5% on Q3 results, pipeline update

Nov 10

CEO報酬分析

Cabaletta Bio の収益と比較して、Steven Nichtberger の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$90m

Mar 31 2024n/an/a

-US$77m

Dec 31 2023US$5mUS$597k

-US$68m

Sep 30 2023n/an/a

-US$62m

Jun 30 2023n/an/a

-US$57m

Mar 31 2023n/an/a

-US$56m

Dec 31 2022US$2mUS$569k

-US$53m

Sep 30 2022n/an/a

-US$51m

Jun 30 2022n/an/a

-US$51m

Mar 31 2022n/an/a

-US$50m

Dec 31 2021US$4mUS$542k

-US$46m

Sep 30 2021n/an/a

-US$42m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$36m

Dec 31 2020US$4mUS$516k

-US$33m

Sep 30 2020n/an/a

-US$29m

Jun 30 2020n/an/a

-US$26m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$1mUS$437k

-US$22m

Sep 30 2019n/an/a

-US$19m

Jun 30 2019n/an/a

-US$23m

Mar 31 2019n/an/a

-US$21m

Dec 31 2018US$1mUS$213k

-US$12m

報酬と市場: Stevenの 総報酬 ($USD 4.81M ) は、 US市場 ($USD 1.55M ) の同規模の企業の平均を上回っています。

報酬と収益: Stevenの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Steven Nichtberger (63 yo)

7.7yrs

在職期間

US$4,808,279

報酬

Dr. Steven A. Nichtberger, M.D., serves as managing partner of GBF Advisors, LLC. Dr. Nichtberger is an adjunct professor at The Wharton School at the University of Pennsylvania. He is Co-Founder of Cabale...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Steven Nichtberger
Co-Founder7.7yrsUS$4.81m2.76%
$ 5.4m
David Chang
Chief Medical Officer5.3yrsUS$2.10m0%
$ 0
Gwendolyn Binder
President of Science & Technologyno dataUS$2.34m0.041%
$ 80.4k
Michael Milone
Co-Founder & Co-Chair of Scientific Advisory Boardno dataデータなしデータなし
Aimee Payne
Co-Founder & Co-Chair of Scientific Advisory Boardno dataデータなしデータなし
Anup Marda
Chief Financial Officer5.7yrsUS$1.53mデータなし
Qing Yuan
Chief Technology Officerless than a yearデータなしデータなし
Samik Basu
Chief Scientific Officer2.8yrsデータなしデータなし
Michael Gerard
General Counsel & Secretary3yrsデータなしデータなし
Heather Harte-Hall
Chief Compliance Officer2.8yrsデータなしデータなし
Martha O'Connor
Chief Human Resources Officer5.5yrsデータなしデータなし
Arun Das
Chief Business Officer2.7yrsデータなしデータなし

3.0yrs

平均在職期間

49yo

平均年齢

経験豊富な経営陣: CABAの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Steven Nichtberger
Co-Founder7.7yrsUS$4.81m2.76%
$ 5.4m
Michael Milone
Co-Founder & Co-Chair of Scientific Advisory Boardno dataデータなしデータなし
Aimee Payne
Co-Founder & Co-Chair of Scientific Advisory Boardno dataデータなしデータなし
Richard Henriques
Independent Director5.6yrsUS$259.20k0%
$ 0
Carl June
Member of Scientific Advisory Board4.1yrsデータなしデータなし
Mark Simon
Independent Director5.9yrsUS$260.15k0.29%
$ 575.4k
Brian Daniels
Member of Scientific Advisory Board3.3yrsUS$202.24kデータなし
Scott Brun
Independent Director3.3yrsUS$255.83k0%
$ 0
Iain McInnes
Member of Scientific Advisory Board4.7yrsデータなしデータなし
Jay Siegel
Member of Scientific Advisory Boardno dataデータなしデータなし
Drew Weissman
Member of Scientific Advisory Board2.8yrsデータなしデータなし
Catherine Bollard
Independent Director5.4yrsUS$255.43k0.0021%
$ 4.0k

4.7yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: CABAの 取締役会経験豊富 であると考えられます ( 4.4年の平均在任期間)。